Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test. The continued expansion of tumor-agnostic CDx claims underscores Illumina’s commitment to advance access for […]
SALT LAKE CITY and BOSTON — Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad’s advanced laboratory capabilities in the […]
ZEISS and Concept Life Sciences announce partnership Jena, Germany | ZEISS Research Microscopy Solutions — ZEISS Microscopy and Concept Life Sciences, a UK-based contract research organization (CRO), announced their collaboration aimed at pioneering new approaches to workflow automation and scalable image analysis in spatial biology. Key focus areas of the collaboration are: Automated high-throughput imaging […]
Merck KGaA and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry. Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens Xcelerator Platform and Life Science portfolio of Merck KGaA, Darmstadt, Germany Joint projects include developing AI-driven […]
MoU signed to deliver end-to-end digital workflows from drug discovery to manufacturing through combination of technology from the Siemens Xcelerator platform and Merck’s Life Sciences portfolio Joint projects include developing AI-driven tools and digital interfaces that simplify complex scientific processes Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership […]
BOSTON — SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS’s AI […]
Curated range of premium spectrometers now available for sourcing directly from Edmund Optics Barrington, NJ USA — Edmund Optics®, a leading global provider of optical and imaging components, is proud to announce a new Supplier Partner relationship with Ocean Optics and the global launch of a curated selection of Ocean Optics’ premium spectrometers and accessories through its […]
New biocrates metabolomics/lipidomics offering enhances Biognosys’ proteomics capabilities to support multiomic drug discovery and clinical/translational research BOSTON, Massachusetts and ZUERICH, Switzerland – Biognosys, a pioneer in next-generation proteomics services and software, today announced the expansion of its contract research organization (CRO) services to include quantitative biocrates metabolomics and lipidomics. These services will be offered both […]
Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of ‘gene silencing’ medicines Members leverage AI-powered dataset to accelerate pharma R&D, andensure that disease-impacting discoveries benefit all people SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) (Alnylam) as […]
The new co-marketing and distribution partnership enables SureSeq™ NGS panel customers to purchase QIAGEN’s tertiary analysis software QIAGEN Clinical Insight (QCI®) Interpret as part of a complete SureSeq NGS workflow solution, unlocking comprehensive analysis from sample to report QIAGEN Digital Insights bioinformatics bring over 25 years of expertise in expert-curated content, AI-powered proprietary algorithms and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
